Balchem Corp
BCPC150.500USD
-2.850-1.86%
Handelsschluss 12/05, 16:00（ET）Kurse um 15 Minuten verzögert
4.87BMarktkapitalisierung
32.66KGV TTM
mehr Informationen über Balchem Corp Unternehmen
Balchem Corporation develops, manufactures, distributes and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition and industrial markets. The Company's segments include Human Nutrition and Health (HNH), Animal Nutrition and Health (ANH), and Specialty Products. The HNH segment provides human grade choline nutrients and mineral amino acid chelated products for nutrition and health applications. This segment also manufactures specialty vitamin K2, which plays a role in the human body for bone health, heart health and immunity, and methylsulfonylmethane (MSM). ANH segment provides nutritional products derived from its microencapsulation and chelation technologies in addition to the nutrient choline chloride. Through Specialty Products, it re-packages and distributes a number of gases and chemicals for various uses by its customers, notably ethylene oxide, propylene oxide, and ammonia.
Balchem Corp Informationen
BörsenkürzelBCPC
Name des UnternehmensBalchem Corp
IPO-datumJun 03, 1986
CEOMr. Theodore L. (Ted) Harris
Anzahl der mitarbeiter1361
WertpapierartOrdinary Share
GeschäftsjahresendeJun 03
Addresse- -
Stadt- -
BörseNASDAQ Global Select Consolidated
Land- -
Postleitzahl- -
Telefon- -
Website- -
BörsenkürzelBCPC
IPO-datumJun 03, 1986
CEOMr. Theodore L. (Ted) Harris
Führungskräfte von Balchem Corp
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Theodore L. (Ted) Harris
Mr. Theodore L. (Ted) Harris
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
61.58K
-0.77%
Mr. David B. (Dave) Fischer
Mr. David B. (Dave) Fischer
Independent Director
Independent Director
5.94K
-25.19%
Ms. Hatsuki Miyata
Ms. Hatsuki Miyata
Executive Vice President, Chief Legal Officer and Secretary
Executive Vice President, Chief Legal Officer and Secretary
1.55K
-23.80%
Mr. Frederic Boned
Mr. Frederic Boned
Senior Vice President, General Manager - Human Nutrition and Health
Senior Vice President, General Manager - Human Nutrition and Health
410.00
-78.03%
Mr. Matthew D. (Matt) Wineinger
Mr. Matthew D. (Matt) Wineinger
Lead Independent Director
Lead Independent Director
--
--
Mr. C. Martin Bengtsson
Mr. C. Martin Bengtsson
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
--
--
Ms. Monica Vicente
Ms. Monica Vicente
Independent Director
Independent Director
--
-100.00%
Mr. Olivier Rigaud
Mr. Olivier Rigaud
Independent Director
Independent Director
--
-100.00%
Mr. Daniel E. Knutson, CPA
Mr. Daniel E. Knutson, CPA
Independent Director
Independent Director
--
--
Mr. Martin L. Reid
Mr. Martin L. Reid
Senior Vice President and Chief Supply Chain Officer
Senior Vice President and Chief Supply Chain Officer
--
--
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Theodore L. (Ted) Harris
Mr. Theodore L. (Ted) Harris
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
61.58K
-0.77%
Mr. David B. (Dave) Fischer
Mr. David B. (Dave) Fischer
Independent Director
Independent Director
5.94K
-25.19%
Ms. Hatsuki Miyata
Ms. Hatsuki Miyata
Executive Vice President, Chief Legal Officer and Secretary
Executive Vice President, Chief Legal Officer and Secretary
1.55K
-23.80%
Mr. Frederic Boned
Mr. Frederic Boned
Senior Vice President, General Manager - Human Nutrition and Health
Senior Vice President, General Manager - Human Nutrition and Health
410.00
-78.03%
Mr. Matthew D. (Matt) Wineinger
Mr. Matthew D. (Matt) Wineinger
Lead Independent Director
Lead Independent Director
--
--
Mr. C. Martin Bengtsson
Mr. C. Martin Bengtsson
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
--
--
Umsatzaufteilung
Währung: USDAktualisiert: Mon, Oct 6
Währung: USDAktualisiert: Mon, Oct 6
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
Product Sales Revenue
255.04M
99.83%
Royalty
426.00K
0.17%
Nach RegionUSD
Name
Umsatz
Anteil
United States
186.71M
73.08%
Foreign Countries
68.76M
26.92%
Nach Geschäftsbereich
Nach Region
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
Product Sales Revenue
255.04M
99.83%
Royalty
426.00K
0.17%
Aktionärsstatistik
Aktualisiert: Wed, Oct 8
Aktualisiert: Wed, Oct 8
Aktionäre
Aktionärstypen
Aktionäre
Aktionäre
Anteil
BlackRock Institutional Trust Company, N.A.
13.43%
The Vanguard Group, Inc.
12.00%
Conestoga Capital Advisors, LLC
3.93%
State Street Investment Management (US)
3.71%
Wasatch Global Investors Inc
3.34%
Andere
63.60%
Aktionäre
Aktionäre
Anteil
BlackRock Institutional Trust Company, N.A.
13.43%
The Vanguard Group, Inc.
12.00%
Conestoga Capital Advisors, LLC
3.93%
State Street Investment Management (US)
3.71%
Wasatch Global Investors Inc
3.34%
Andere
63.60%
Aktionärstypen
Aktionäre
Anteil
Investment Advisor
51.15%
Investment Advisor/Hedge Fund
28.70%
Hedge Fund
6.00%
Pension Fund
2.43%
Research Firm
1.95%
Sovereign Wealth Fund
1.59%
Bank and Trust
1.04%
Individual Investor
0.54%
Family Office
0.06%
Andere
6.54%
Institutionelle Beteiligung
Aktualisiert: Wed, Oct 1
Aktualisiert: Wed, Oct 1
Berichtszeitraum
Anzahl der Institutionen
Gehaltenen Aktien
Anteil
Veränderung
2025Q3
686
30.06M
92.82%
-118.69K
2025Q2
674
29.83M
91.92%
-576.99K
2025Q1
675
29.77M
91.28%
-552.46K
2024Q4
651
29.73M
91.39%
-1.02M
2024Q3
627
29.81M
91.89%
-780.47K
2024Q2
615
29.69M
91.57%
-1.10M
2024Q1
605
29.82M
92.42%
-671.07K
2023Q4
593
29.66M
91.98%
-739.65K
2023Q3
584
29.65M
91.97%
-680.11K
2023Q2
572
29.77M
92.37%
-504.52K
Mehr Anzeigen
Aktionärsaktivitäten
Name
Gehaltenen Aktien
Anteil
Veränderung
Änderung%
Datum
BlackRock Institutional Trust Company, N.A.
4.44M
13.67%
-111.30K
-2.45%
Jun 30, 2025
The Vanguard Group, Inc.
3.89M
11.99%
+47.60K
+1.24%
Jun 30, 2025
Conestoga Capital Advisors, LLC
1.15M
3.54%
-19.03K
-1.63%
Jun 30, 2025
State Street Investment Management (US)
1.23M
3.78%
-1.53K
-0.12%
Jun 30, 2025
Wasatch Global Investors Inc
960.09K
2.96%
-108.92K
-10.19%
Jun 30, 2025
Geode Capital Management, L.L.C.
980.97K
3.02%
+14.33K
+1.48%
Jun 30, 2025
Geneva Capital Management LLC
895.53K
2.76%
+64.72K
+7.79%
Jun 30, 2025
Dimensional Fund Advisors, L.P.
575.40K
1.77%
-18.35K
-3.09%
Jun 30, 2025
Norges Bank Investment Management (NBIM)
469.08K
1.45%
+38.60K
+8.97%
Jun 30, 2025
JP Morgan Asset Management
389.05K
1.2%
-7.19K
-1.82%
Jun 30, 2025
Mehr Anzeigen
Verbundene ETFs
Aktualisiert: Sat, Dec 6
Aktualisiert: Sat, Dec 6
Name
Anteil
Invesco S&P SmallCap Materials ETF
6.89%
Invesco S&P SmallCap Quality ETF
1.2%
First Trust Horizon Managed Vol Small/Mid ETF
1.05%
ProShares Russell 2000 Dividend Growers ETF
0.91%
Invesco S&P SmallCap Low Volatility ETF
0.87%
State Street SPDR S&P 600 Small Cap Growth ETF
0.68%
Vanguard S&P Small-Cap 600 Growth Index Fund
0.64%
iShares S&P Small-Cap 600 Growth ETF
0.63%
Pacer US Small Cap Cash Cows Growth Leaders ETF
0.57%
Parametric Equity Premium Income ETF
0.56%
Mehr Anzeigen
Invesco S&P SmallCap Materials ETF
Anteil6.89%
Invesco S&P SmallCap Quality ETF
Anteil1.2%
First Trust Horizon Managed Vol Small/Mid ETF
Anteil1.05%
ProShares Russell 2000 Dividend Growers ETF
Anteil0.91%
Invesco S&P SmallCap Low Volatility ETF
Anteil0.87%
State Street SPDR S&P 600 Small Cap Growth ETF
Anteil0.68%
Vanguard S&P Small-Cap 600 Growth Index Fund
Anteil0.64%
iShares S&P Small-Cap 600 Growth ETF
Anteil0.63%
Pacer US Small Cap Cash Cows Growth Leaders ETF
Anteil0.57%
Parametric Equity Premium Income ETF
Anteil0.56%
Dividende
In den vergangenen 5 Jahren wurden insgesamt
104.59M
USD an Dividenden ausgeschüttet.
Datum
Dividende
Stichtag für die Aktienregistrierung
Zahltag
Ex-Dividendentag
Dec 10, 2024
BCPC.NB Final Cash Dividend of gross USD 0.87 paid on Jan 17, 2025 going ex on Dec 26, 2024
Dec 26, 2024
Jan 17, 2025
Dec 26, 2024
Dec 05, 2023
BCPC.NB Final Cash Dividend of gross USD 0.79 paid on Jan 19, 2024 going ex on Dec 26, 2023
Dec 27, 2023
Jan 19, 2024
Dec 26, 2023
Dec 06, 2022
BCPC.NB Final Cash Dividend of gross USD 0.71 paid on Jan 20, 2023 going ex on Dec 23, 2022
Dec 27, 2022
Jan 20, 2023
Dec 23, 2022
Dec 16, 2021
BCPC.NB Final Cash Dividend of gross USD 0.64 paid on Jan 21, 2022 going ex on Dec 27, 2021
Dec 28, 2021
Jan 21, 2022
Dec 27, 2021
Dec 17, 2020
BCPC.NB Final Cash Dividend of gross USD 0.58 paid on Jan 22, 2021 going ex on Dec 24, 2020
Dec 28, 2020
Jan 22, 2021
Dec 24, 2020
Aktien-Split
Datum
Art
Verhältnis
Keine Daten
Datum
Art
Verhältnis
Keine Daten
Häufig gestellte Fragen
Wer sind die fünf größten Anteilseigner von Balchem Corp?
Die fünf größten Anteilseigner von Balchem Corp sind:
BlackRock Institutional Trust Company, N.A. hält 4.44M Aktien, was 13.67% der Gesamtaktien entspricht.
The Vanguard Group, Inc. hält 3.89M Aktien, was 11.99% der Gesamtaktien entspricht.
Conestoga Capital Advisors, LLC hält 1.15M Aktien, was 3.54% der Gesamtaktien entspricht.
State Street Investment Management (US) hält 1.23M Aktien, was 3.78% der Gesamtaktien entspricht.
Wasatch Global Investors Inc hält 960.09K Aktien, was 2.96% der Gesamtaktien entspricht.
BlackRock Institutional Trust Company, N.A. hält 4.44M Aktien, was 13.67% der Gesamtaktien entspricht.
The Vanguard Group, Inc. hält 3.89M Aktien, was 11.99% der Gesamtaktien entspricht.
Conestoga Capital Advisors, LLC hält 1.15M Aktien, was 3.54% der Gesamtaktien entspricht.
State Street Investment Management (US) hält 1.23M Aktien, was 3.78% der Gesamtaktien entspricht.
Wasatch Global Investors Inc hält 960.09K Aktien, was 2.96% der Gesamtaktien entspricht.
Was sind die drei wichtigsten Anteilseigner-Typen von Balchem Corp?
Die drei wichtigsten Anteilseigner-Typen von Balchem Corp sind:
BlackRock Institutional Trust Company, N.A.
The Vanguard Group, Inc.
Conestoga Capital Advisors, LLC
BlackRock Institutional Trust Company, N.A.
The Vanguard Group, Inc.
Conestoga Capital Advisors, LLC
Wie viele Institutionen halten Anteile an Balchem Corp (BCPC)?
Mit Stand vom 2025Q3 halten 686 Institutionen Anteile an Balchem Corp, mit einem Gesamtmarktwert von etwa 30.06M, was 92.82% der Gesamtanteile entspricht. Im Vergleich zum 2025Q2 ist der institutionelle Aktienbesitz um 0.91% gestiegen.
Was ist die größte Einnahmequelle von Balchem Corp?
Am FY2025Q2 erzielte das Geschäft mit Product Sales Revenue für Balchem Corp den höchsten Umsatz in Höhe von 255.04M, was 99.83% des Gesamtumsatzes entspricht.
